Simplifying Global Compliance
FDA Extends Comment Period for Combo Products Rule
Devices & Diagnostics Letter
At the request of stakeholders, the FDA has extended the comment period to Feb. 5 on a proposed rule on good manufacturing practices (GMPs) for combination products.
To View This Article:
Buy This Article Now
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing